Search Results for: hepatitis C virus

March 7, 2017March 7, 2017

Developing HCV Vaccine May Be Possible by Exposing Virus to Immune System Attack

Hepatitis C, News

Manipulating the major protein of the hepatitis C virus (HCV) allows the virus to be exposed in a way that the immune system can efficiently detect and attack it. This finding ... Read more

March 2, 2017March 2, 2017

New Collective Drug Price Will Provide More Canadians Access to Hepatitis C Treatment

Hepatitis C, News

About 75,000 people in the Canadian province of British Columbia (B.C.) estimated to have hepatitis C will soon have better access to treatment for this potentially life-threatening disease. The B.C. Ministry ... Read more

February 14, 2017February 14, 2017

EMA Committee Rules Favorably on VBI Vaccine for Hepatitis B

Hepatitis B, News

A committee of the European Union’s drug regulatory agency has given its blessing to Sci-B-Vac, a vaccine for hepatitis B developed by Massachusetts-based VBI Vaccines. The Committee for Medicinal Products for Human ... Read more

February 9, 2017February 9, 2017

NIH Awards $416,000 to Saint Louis Researchers to Advance Potential Cure for Hepatitis B

Hepatitis B, News

Researchers at Missouri’s Saint Louis University (SLU) — hoping to advance understanding on how hepatitis B virus (HBV) replicates — aim to develop a new drug that could cure this viral infection. John Tavis, PhD, professor of ... Read more

February 7, 2017February 7, 2017

Hepatitis C Therapy Candidate Granted Priority Review from Health Canada

Hepatitis C, News

A potential new drug being developed for the treatment of chronic hepatitis C received priority review from Health Canada. This means that the compound may be reviewed in advance of ... Read more

January 24, 2017January 24, 2017

GeoVax and Georgia State Working on Hepatitis B Therapeutic Vaccine

Hepatitis B, News

GeoVax Labs and the Georgia State University Research Foundation have entered a research agreement to develop a therapeutic vaccine for chronic hepatitis B virus (HBV) infections. Georgia State will combine its preS VLP ... Read more

January 17, 2017January 17, 2017

Vemlidy, for Chronic Hepatitis B Infection, Approved in Europe

Hepatitis B, News

The European Union has granted marketing authorization for Vemlidy (tenofovir alafenamide, or TAF), Gilead Sciences’ pioneering treatment for chronic hepatitis B virus (HBV) infection in adults and teens with compensated liver ... Read more

January 12, 2017January 12, 2017

AbbVie’s One-Pill Combo Therapy Shows Promise for Hepatitis C in Japanese Trial

Hepatitis C, News

AbbVie’s new hepatitis C treatment candidate, a one tablet combination of the investigational drugs glecaprevir and pibrentasvir, harnessed the infection in all patients who completed a Japanese study. The treatment, ... Read more

January 10, 2017January 10, 2017

Blacks, Hispanics with Hepatitis C More Likely to Fail Treatment with Direct-Acting Antiviral Agents

Hepatitis C, News

Within the U.S. Veterans Affairs’ healthcare system, black and Hispanic patients with hepatitis C are more likely to fail treatment with direct-acting antiviral (DAAs) drugs, than patients who are white, a ... Read more

January 5, 2017January 5, 2017

ContraVir Awarded $224K Research Grant to Advance Potential Hepatitis B Treatment

Hepatitis B, News

The National Research Council (NRC) in Canada has awarded ContraVir Pharmaceuticals more than $224,000 to cover expenses related to the preclinical development of CRV431, the company’s cyclophilin inhibitor for the treatment of hepatitis B virus (HBV). The research award, ... Read more